Bio-Rad Technical Note
Describes Chromatographic Method Monitoring
HERCULES,
Calif., April 21, 2008 – Bio-Rad
Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and
distributor of life science research and clinical diagnostic products, announced
today the availability of a technical note (tech note 5506A) entitled, “Monitoring Development of Chromatographic Methods with the
Experion™ Automated Electrophoresis System,” which demonstrates how the
Experion automated electrophoresis system and associated Pro260 analysis kit can
be used together to accelerate the process of developing a purification scheme
for an antibody or other protein.
The technical note provides
an analysis of methods enabling the Experion Pro260, which is comparable to
traditional SDS-PAGE in terms of performance (Chang et al. 2005, Zhu et al.
2005) but also in meeting the need for quick data acquisition during process
development.
The four-page technical
note is available by visiting the Bio-Rad website at http://www.bio-rad.com/cmc_upload/Literature/204027/Bulletin_5506A.pdf.
About the Experion Automated Electrophoresis
System
Using
a combination of microfluidics and electrophoresis, Bio-Rad’s Experion
electrophoresis system enables sensitive, high resolution separation and data
analysis of protein and RNA samples. The system offers a number of advantages
over traditional gel electrophoresis, such as faster results, reduced sample
and reagent usage, automatic calculations, reduced hands-on time, and
elimination of the challenges of having to work with hazardous materials typically
associated with these applications. For example, Experion analysis — from
sample preparation through the chip run — can be achieved in as little as 30
minutes compared to the two-to-three hours generally required for SDS-PAGE.
About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of
scientific discovery for more than 50 years manufacturing and distributing a
broad range of products for the life science research and clinical diagnostic
markets. The company is renowned worldwide among hospitals, universities, major
research institutions, as well as biotechnology and pharmaceutical companies
for its commitment to quality and customer service. Founded in 1952, Bio-Rad is
headquartered in Hercules, California, and serves more than 85,000 research and
industry customers worldwide through its global network of operations. The
company employs approximately 6,300 people
globally and had revenues approaching $1.5 billion in 2007. For more
information, visit www.bio-rad.com.
For more
information contact:
Mary Grace Brubacher
Bio-Rad Laboratories, Inc.
510-724-5347
MaryGrace_Brubacher@bio-rad.com